NASDAQ:ENOB
Delisted
Enochian Biosciences Inc. Stock News
$0.700
+0 (+0%)
At Close: Nov 24, 2023
ENOB Stock Price Increases Over 40% Pre-Market: Why It Happened
06:33am, Thursday, 25'th Mar 2021
The stock price of Enochian Biosciences Inc (NASDAQ: ENOB) has increased by over 40% pre-market. This is why it happened.
LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Seraph Research Institute (SRI) and Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in i
Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference
05:15pm, Monday, 22'nd Feb 2021
LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be
Baby Bonds Complete Review
02:51am, Thursday, 20'th Aug 2020
A review of all baby bonds. All the baby bonds sorted in categories.
The
Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board
12:00pm, Monday, 27'th Jul 2020
Drs. Carol Brosgart, Peter Revill and Fabien Zoulim will advise on development of a cure for Hepatitis BLOS ANGELES, July 27, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, a comp
HD Medical obtient l'autorisation de la FDA pour HD Steth
12:00am, Tuesday, 14'th Jul 2020
HD Medical, Inc. de Silicon Valley annonce aujourd'hui que son produit phare, HD Steth, est autorisé par la FDA pour les trois codes de classification
Stopping Systemic Racism From Shortening Black Lives
01:19pm, Wednesday, 01'st Jul 2020
Recently, I joined a couple hundred health care practitioners, faculty, and students from VCU who gathered as part of White Coats for Bl ...
U.S. Colorectal Cancer Market and Competitive Landscape Assessment 2016-2025 - ResearchAndMarkets.com
12:00am, Wednesday, 17'th Jun 2020
The
Kiniksa Positive COVID-19 Data And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:KNSA)
08:59am, Wednesday, 10'th Jun 2020
Kiniksa announces positive COVID-19 trial. Astellas Phase 3 anemia study reports positive data. Enochian BioSciences progresses with HIV drug.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 8)
Biohaven Pharmaceutical...
Xbox Series X: Everything We Know About the Next-Gen Game Console | Digital Trends
06:35pm, Monday, 08'th Jun 2020
Xbox Series X, the followup to Xbox One, is coming soon, but there's still a lot we don't know. Here's what we know so far, including price and release date.
Stocks Piggyback Off Last Week's Rally - Schaeffer's Investment Research
04:11pm, Monday, 08'th Jun 2020
Stocks are gaining momentum off last week's impressive rally
Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV
11:30am, Monday, 08'th Jun 2020
LOS ANGELES, June 08, 2020 (GLOBE NEWSWIRE) -- (ENOB) - Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announce
Here's Why Small-Cap Biopharma Enochian Is Surging Higher
12:00am, Monday, 08'th Jun 2020
Shares of Enochian Biosciences Inc (NASDAQ: ENOB) were trading more than 75% higher Monday in reaction to the company's announcement regarding a positive FDA meeting...